Citation Impact
Citing Papers
Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach
2012 Standout
Death from Bronchial Asthma
1988 Standout
Review of the mechanism of cell death resulting from streptozotocin challenge in experimental animals, its practical use and potential risk to humans
2013 Standout
Modulation of gut microbiota by berberine and metformin during the treatment of high-fat diet-induced obesity in rats
2015 Standout
The prince and the pauper. A tale of anticancer targeted agents
2008
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2007 Standout
High-dose Inhaled Albuterol in Severe Chronic Airflow Limitation
1988
Effect of mangiferin on hyperglycemia and atherogenicity in streptozotocin diabetic rats
2005 Standout
Role of AMP-activated protein kinase in mechanism of metformin action
2001 Standout
Pharmacokinetics of metformin after enteral administration in insulin-resistant ponies
2010
The metabolic syndrome
2010 Standout
Global Initiative for Chronic Obstructive Lung Disease
2002 Standout
Metformin Transport by a Newly Cloned Proton-Stimulated Organic Cation Transporter (Plasma Membrane Monoamine Transporter) Expressed in Human Intestine
2007
Clinical Pharmacokinetics of Metformin
2011
Clinical practice guidelines for the perioperative nutritional, metabolic, and nonsurgical support of the bariatric surgery patient—2013 update: Cosponsored by american association of clinical endocrinologists, The obesity society, and american society for metabolic & bariatric surgery*
2013 Standout
Effect of metformin on glucose metabolism in the splanchnic bed
1992
Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study
2000 Standout
Respiratory Arrest in near-Fatal Asthma
1991 Standout
The mechanisms of action of metformin
2017 Standout
NRF2 and NF-қB interplay in cerebrovascular and neurodegenerative disorders: Molecular mechanisms and possible therapeutic approaches
2018 Standout
Clinical Pharmacokinetics of Metformin
1996
Once-daily delayed-release metformin lowers plasma glucose and enhances fasting and postprandial GLP-1 and PYY: results from two randomised trials
2016
Pharmacological Management of Diabetes
1999
The metabolic syndrome
2005 Standout
The Effect of Intravenous Metformin on Glucose Metabolism During Hyperglycaemia in Type 2 Diabetes
1992
Metformin suppresses gluconeogenesis by inhibiting mitochondrial glycerophosphate dehydrogenase
2014 StandoutNature
Coumarins: Old Compounds with Novel Promising Therapeutic Perspectives
2010 Standout
Dose-Independent Pharmacokinetics of Metformin in Rats: Hepatic and Gastrointestinal First-Pass Effects
2006
Type 2 diabetes
2017 Standout
Biguanides suppress hepatic glucagon signalling by decreasing production of cyclic AMP
2013 Nature
Metformin hydrochloride in the treatment of type 2 diabetes mellitus: A clinical review with a focus on dual therapy
2003
Equine Metabolic Syndrome
2010 Standout
Metformin: An Old Drug for the Treatment of Diabetes but a New Drug for the Protection of the Endothelium
2015
Pharmacokinetics of Oral Antihyperglycaemic Agents in Patients with Renal Insufficiency
1996
Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
2012 Standout
Involvement of Organic Cation Transporter 1 in Hepatic and Intestinal Distribution of Metformin
2002
Metformin and the gastrointestinal tract
2016
Pharmacokinetic-Pharmacodynamic Analysis of the Glucose-Lowering Effect of Metformin in Diabetic Rats Reveals First-Pass Pharmacodynamic Effect
2002
Accumulation of metformin by tissues of the normal and diabetic mouse
1994
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2001 Standout
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Management of Hyperglycemia in Type 2 Diabetes, 2015: A Patient-Centered Approach: Update to a Position Statement of the American Diabetes Association and the European Association for the Study of Diabetes
2014 Standout
Pharmacokinetics of drugs in rats with diabetes mellitus induced by alloxan or streptozocin: comparison with those in patients with type I diabetes mellitus
2010
Beta 1- and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure.
1986 Standout
Effect of Gastric Bypass Surgery on the Absorption and Bioavailability of Metformin
2011
The Primary Glucose-Lowering Effect of Metformin Resides in the Gut, Not the Circulation: Results From Short-term Pharmacokinetic and 12-Week Dose-Ranging Studies
2015
Guidelines for the Primary Prevention of Stroke
2014 Standout
Special Issue: KDIGO Clinical Practice Guideline for the Care of Kidney Transplant Recipients
2009 Standout
Subcellular distribution of metformin in rat liver
1991
Repurposing metformin: an old drug with new tricks in its binding pockets
2015
The COPDX Plan: Australian and New Zealand Guidelines for the management of Chronic Obstructive Pulmonary Disease 2003
2003 Standout
Beneficial hemodynamic effects of intravenous terbutaline in patients with severe heart failure
1982
Use of Metformin in the Setting of Mild-to-Moderate Renal Insufficiency
2011
Concomitant use of beta adrenergic agonists and methylxanthines
1984
Evidence that metformin exerts its anti-diabetic effects through inhibition of complex 1 of the mitochondrial respiratory chain
2000 Standout
Works of PJ Phillips being referenced
Metformin kinetics in healthy subjects and in patients with diabetes mellitus.
1981
Metabolic and cardiovascular side effects of the beta 2‐adrenoceptor agonists salbutamol and rimiterol.
1980